Currently, the biomarkers for AKI include NGAL, KIM-1, TIMP-1, liver-type fatty acid-binding protein (L-FABP), interleukin-18 (IL-18), insulin-like growth factor-binding protein 7 (IGFBP7), and others [20,21]. This evidence concerns the gene IL18 and acute kidney injury.